Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - metolazone 5 mg - tablets - metolazone - for the treatment of salt and water retention including: edema accompanying congestive heart failure, edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function. for hypertension, alone or in combination with other antihypertensive drugs of a different class.

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - prednisone 1 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - prednisone 1 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - prednisone 2 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - prednisone 2 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - prednisone 5 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - prednisone 5 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - pramipexole dihydrochloride monohydrate 0.375 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - pramipexole dihydrochloride monohydrate 0.75 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.

Izraēla - ivrits - Ministry of Health

rafa laboratories ltd - pramipexole dihydrochloride monohydrate 1.5 mg - tablets extended release - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.